Estrogen Treatment After Ovariectomy Protects Against Fatty Liver and May Improve Pathway-Selective Insulin Resistance
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Pathway-selective insulin resistance where insulin fails to suppress hepatic glucose production but promotes liver fat storage may underlie glucose and lipid abnormalities after menopause. We tested the mechanisms by which estrogen treatment may alter the impact of a high-fat diet (HFD) when given at the time of ovariectomy (OVX) in mice. Female C57BL/6J mice underwent sham operation, OVX, or OVX with estradiol (E2) treatment and were fed an HFD. Hyperinsulinemic-euglycemic clamps were used to assess insulin sensitivity, tracer incorporation into hepatic lipids, and liver triglyceride export. OVX mice had increased adiposity that was prevented with E2 at the time of OVX. E2 treatment increased insulin sensitivity with OVX and HFD. In sham and OVX mice, HFD feeding induced fatty liver, and insulin reduced hepatic apoB100 and liver triglyceride export. E2 treatment reduced liver lipid deposition and prevented the decrease in liver triglyceride export during hyperinsulinemia. In mice lacking the liver estrogen receptor α, E2 after OVX limited adiposity but failed to improve insulin sensitivity, to limit liver lipid deposition, and to prevent insulin suppression of liver triglyceride export. In conclusion, estrogen treatment may reverse aspects of pathway-selective insulin resistance by promoting insulin action on glucose metabolism but limiting hepatic lipid deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Estrogen treatment promotes anti-inflammatory and insulin sensitizing effects in both male and female mice (80, 81), and estrogen replacement reverses some of the detrimental metabolic effects of ovariectomy (80, 82–84).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Years of Life Lost Due to Obesity
Fontaine, K. R., Redden, D. T., Wang, C., Westfall, A. O., & Allison, D. B. (2003) · JAMA · doi:10.1001/jama.289.2.187 · Cited by 2,495
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Self-citationIntrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Magnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115997 · Cited by 757 · cited 3×
“E: Livers from mice in a cohort that was fasted but not clamped (2) and after hyperinsulinemic clamp study (+) were used for protein extraction and Western blotting for pACC, total ACC, apoB100, MTP, and PLTP.”
BackgroundMethodLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
Jones, M. E. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., Proietto, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12735 · Cited by 729
Roger, V. L. (2011) · Circulation · Cited by 719
Ayala, J. E., Samuel, V. T., Morton, G. J., Obici, S., Croniger, C. M., Shulman, G. I., Wasserman, D. H., & McGuinness, O. P. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006239 · Cited by 716
Self-citationSex differences in the relation of visceral adipose tissue accumulation to total body fatness
Lemieux, S., Prud'homme, D., Bouchard, C., Tremblay, A., & Després, J. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.4.463 · Cited by 561
Estrogen Regulation of Adiposity and Fuel Partitioning
D'Eon, T. M., Souza, S. C., Aronovitz, M., Obin, M. S., Fried, S. K., & Greenberg, A. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507339200 · Cited by 517
Musatov, S., Chen, W., Pfaff, D. W., Mobbs, C. V., Yang, X.-J., Clegg, D. J., Kaplitt, M. G., & Ogawa, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610787104 · Cited by 516
Lewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502
Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice
Riant, E., Waget, A., Cogo, H., Arnal, J.-F., Burcelin, R., & Gourdy, P. (2009) · Endocrinology · doi:10.1210/en.2008-0971 · Cited by 421 · cited 2×
“This protection may relate to estrogen’s ability to limit liver fat accumulation, thus preventing hepatic insulin resistance (10,11).”
BackgroundIncreased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418 · cited 1×
“4A and C), consistent with other studies showing increased fatty acid oxidation associated with triglyceride accumulation in the liver (32,33).”
BackgroundBryzgalova, G., Gao, H., Ahren, B., Zierath, J. R., Galuska, D., Steiler, T. L., Dahlman-Wright, K., Nilsson, S., Gustafsson, J.-Å., Efendic, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0105-3 · Cited by 384 · cited 1×
“Global loss of estrogen signaling also increases liver fat in several models, including humans with ERa mutations, rodents after OVX, mice with global ERa knockout, and mice lacking aromatase (19,39,40).”
BackgroundPostreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344
Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-α-Deficient Male Mice
Ohlsson, C., Hellberg, N., Parini, P., Vidal, O., Bohlooly, M., Rudling, M., Lindberg, M. K., Warner, M., Angelin, B., & Gustafsson, J.-Å. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3827 · Cited by 332
Ribas, V., Nguyen, M. T. A., Henstridge, D. C., Nguyen, A.-K., Beaven, S. W., Watt, M. J., & Hevener, A. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2009 · Cited by 309 · cited 2×
“Mice with global ERa deletion have increased adiposity and insulin resistance (11,18,19).”
BackgroundContribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
Tamura, S., & Shimomura, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524930 · Cited by 287
Mao, J., DeMayo, F. J., Li, H., Abu-Elheiga, L., Gu, Z., Shaikenov, T. E., Kordari, P., Chirala, S. S., Heird, W. C., & Wakil, S. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603115103 · Cited by 285
Overproduction of VLDL 1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia
Adiels, M., Borén, J., Caslake, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S.-O., Packard, C., & Taskinen, M.-R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000172689.53992.25 · Cited by 269
Mortality Rates and Risk Factors for Coronary Disease in Black as Compared with White Men and Women
Keil, J. E., Sutherland, S. E., Knapp, R. G., Lackland, D. T., Gazes, P. C., & Tyroler, H. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290201 · Cited by 267
Neschen, S., Morino, K., Hammond, L. E., Zhang, D., Liu, Z.-X., Romanelli, A. J., Cline, G. W., Pongratz, R. L., Zhang, X.-M., Choi, C. S., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.006 · Cited by 261 · cited 1×
“Fatty liver and the accumulation of diacylglycerol may promote the development of hepatic insulin resistance (30).”
BackgroundAyala, J. E., Bracy, D. P., Julien, B. M., Rottman, J. N., Fueger, P. T., & Wasserman, D. H. (2007) · Diabetes · doi:10.2337/db06-0883 · Cited by 237
Lipodystrophy: metabolic insights from a rare disorder
Huang-Doran, I., Sleigh, A., Rochford, J. J., O'Rahilly, S., & Savage, D. B. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0272 · Cited by 215 · cited 1×
“The phenotype of E2 LKO mice with HFD feeding mimics the insulin resistance, dyslipidemia, and hepatic steatosis associated with lean body composition in patients with lipodystrophy (41).”
BackgroundConsoli, A., Nurjhan, N., Reilly, J. J., Bier, D. M., & Gerich, J. E. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114940 · Cited by 204
Tiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44564 · Cited by 180
Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice
Park, C. J., Zhao, Z., Glidewell-Kenney, C., Lazic, M., Chambon, P., Krust, A., Weiss, J., Clegg, D. J., Dunaif, A., Jameson, J. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41702 · Cited by 162
Self-citationTorre, S. D., Rando, G., Meda, C., Stell, A., Chambon, P., Krust, A., Ibarra, C., Magni, P., Ciana, P., & Maggi, A. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.002 · Cited by 156
Self-citationEffect of sex and obesity on basal VLDL-triacylglycerol kinetics
Mittendorfer, B., Patterson, B. W., & Klein, S. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.573 · Cited by 132
Women Produce Fewer but Triglyceride-Richer Very Low-Density Lipoproteins than Men
Magkos, F., Patterson, B. W., Mohammed, B. S., Klein, S., & Mittendorfer, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2215 · Cited by 124
Cirrhosis with steatohepatitis after adjuvant tamoxifen
Oien, K. A., Moffat, D. F. C., Curry, G., Dickson, J., Habeshaw, T., Mills, P. R., & MacSween, R. N. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74872-8 · Cited by 111
Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice
Han, S., Liang, C.-P., Westerterp, M., Senokuchi, T., Welch, C. L., Wang, Q., Matsumoto, M., Accili, D., & Tall, A. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36523 · Cited by 94
Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion
Lie, J., de Crom, R., van Gent, T., van Haperen, R., Scheek, L. M., Lankhuizen, I. M., & van Tol, A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200166-jlr200 · Cited by 89
Pituitary Gonadotroph Estrogen Receptor-α Is Necessary for Fertility in Females
Gieske, M. C., Kim, H. J., Legan, S. J., Koo, Y., Krust, A., Chambon, P., & Ko, C. (2008) · Endocrinology · doi:10.1210/en.2007-1084 · Cited by 74
Self-citationVLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity
Mittendorfer, B., Patterson, B. W., Klein, S., & Sidossis, L. S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00411.2002 · Cited by 57
Demissie, S., Cupples, L. A., Shearman, A. M., Gruenthal, K. M., Peter, I., Schmid, C. H., Karas, R. H., Housman, D. E., Mendelsohn, M. E., & Ordovás, J. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.008 · Cited by 55
Perreault, L., Bergman, B. C., Hunerdosse, D. M., & Eckel, R. H. (2010) · Obesity · doi:10.1038/oby.2010.76 · Cited by 53
Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
Sørensen, L. P., Andersen, I. R., Søndergaard, E., Gormsen, L. C., Schmitz, O., Christiansen, J. S., & Nielsen, S. (2011) · Diabetes · doi:10.2337/db10-0564 · Cited by 51
Evolution of Processes and Regulators of Lipoprotein Synthesis: From Birds to Mammals
Davis, R. A. (1997) · Journal of Nutrition · doi:10.1093/jn/127.5.795s · Cited by 46
Martinez, M. N., Emfinger, C. H., Overton, M., Hill, S., Ramaswamy, T. S., Cappel, D. A., Wu, K., Fazio, S., McDonald, W. H., Hachey, D. L., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m019752 · Cited by 41
Self-citationMicrosomal triglyceride transfer protein expression in adipocytes: A new component in fat metabolism
Swift, L. L., Kakkad, B., Boone, C., Jovanovska, A., Jerome, W. G., Mohler, P. J., & Ong, D. E. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.009 · Cited by 40
Zhu, L., Johnson, C. M., & Bakovic, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800259-jlr200 · Cited by 34
Self-citationRole of Alterations in Systemic, Hepatic, and Muscle Lactate and Alanine Metabolism
Consoli, A., Nurjhan, N., Bier, D. M., & Gerich, J. E. (1990) · Cited by 26
Wu, K., Cappel, D. A., Martinez, M., & Stafford, J. M. (2010) · Endocrinology · doi:10.1210/en.2010-0204 · Cited by 19
Self-citation
Cited by
Sex differences in metabolic regulation and diabetes susceptibility
Tramunt, B., Smati, S., Grandgeorge, N., Lenfant, F., Arnal, J.-F., Montagner, A., & Gourdy, P. (2020) · Diabetologia · doi:10.1007/s00125-019-05040-3 · Cited by 923
Role of Estrogens in the Regulation of Liver Lipid Metabolism
Palmisano, B. T., Zhu, L., & Stafford, J. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_12 · Cited by 527
Self-citationSex differences in lipid and lipoprotein metabolism
Palmisano, B. T., Zhu, L., Eckel, R. H., & Stafford, J. M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.008 · Cited by 522
Self-citationEstrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
Hamilton, K. J., Hewitt, S. C., Arao, Y., & Korach, K. S. (2017) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.12.005 · Cited by 336
Metadata
- Authors
- Zhu, L., Brown, W. C., Cai, Q., Krust, A., Chambon, P., McGuinness, O. P., & Stafford, J. M.
- Affiliations
- VA Tennessee Valley Healthcare System (US)
- Vanderbilt University (US)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Stafford, John M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-01-17
- Volume
- 62
- Issue
- 2
- Pages
- 424-434
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3554377
- OpenAlex
- W2163187036
- Cited by
- 326
- References
- 50
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 23 · 2023: 21 · 2022: 23 · 2021: 28 · 2020: 25 · 2019: 36 · 2018: 25 · 2017: 23 · 2016: 18 · 2015: 26 · 2014: 22 · 2013: 13
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- American Diabetes Association (DK20593)
- U.S. Department of Veterans Affairs
- John A. Hartford Foundation
- American Heart Association (10GRNT3650024, DK20593)
- Hartford Foundation for Public Giving
- Atlantic Philanthropies
- Vanderbilt University (DK20593)
- National Institutes of Health (3p60dk020593-31s3)
- Canadian Institutes of Health Research
- Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center (DK-058404)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK058404, P60-DK020593, DK59637, DK 20593, U24DK059637, P30DK058404, P30DK020593)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- estrogen, estradiol, ovariectomy, menopause, hepatic insulin sensitivity, hepatic steatosis, high-fat diet, hepatic lipid accumulation, adiposity, hepatic glucose production, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Animals, Estradiol, Estrogens, Fatty Liver, Female, Glucose, Hyperinsulinism, Insulin Resistance, Lipids, Liver, Mice, Inbred C57BL, Obesity, Ovariectomy, Triglycerides, Glucose Clamp Technique, Estrogen Receptor alpha, Adiposity, Lipid Metabolism, Mice, Apolipoprotein B-100, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.